Maze Therapeutics GC Courtney Phillips Sells 3,993 Shares

What Happened
Courtney Phillips, General Counsel and Corporate Secretary of Maze Therapeutics (MAZE), sold a total of 3,993 shares in open‑market transactions on Sept. 2–3, 2026, generating aggregate proceeds of approximately $104,764. The sales were reported as disposals (code S) and, per the filing, were executed to satisfy tax‑withholding obligations arising from the vesting of restricted stock units.

Key Details

• Transactions reported:
  • 2026-09-02: 1,738 shares at a weighted average price of $26.38 — $45,841
  • 2026-09-02: 243 shares at a weighted average price of $27.12 — $6,590
  • 2026-09-03: 1,990 shares at a weighted average price of $26.01 — $51,766
  • 2026-09-03: 22 shares at a weighted average price of $25.78 — $567
• Total sold: 3,993 shares for about $104,764.
• Footnotes:
  • F1: Sales were to satisfy tax‑withholding obligations from RSU vesting (routine administrative sale).
  • F2–F4: Reported prices are weighted averages; the filing gives price ranges across the individual trades (approximately $25.743 to $27.40). The reporting person can provide per‑trade prices on request.
• Shares owned after the transactions: not specified in the supplied filing excerpt.
• Filing timeliness: Transactions occurred Sept. 2–3 and the Form 4 was filed Sept. 4, 2026 — consistent with the usual two‑business‑day filing requirement (i.e., appears timely).

Context

• These were tax‑withholding sales tied to RSU vesting (code/label F for tax withholding), which are routine and administrative rather than discretionary purchases or sales expressing a new view on the stock. Sales to cover taxes do not necessarily indicate insider sentiment about the company’s prospects.
• Transaction code: S = Sale; F (tax withholding) indicates shares were surrendered/sold to cover taxes on vested awards.